News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
867,251 Results
Type
Article (87777)
Company Profile (824)
Press Release (778634)
Multimedia
Podcasts (187)
Webinars (28)
Section
Business (233175)
Career Advice (4144)
Deals (39840)
Drug Delivery (144)
Drug Development (91363)
Employer Resources (203)
FDA (18360)
Job Trends (17415)
News (397727)
Policy (39949)
Tag
Academia (3006)
Academic (2)
Accelerated approval (27)
Adcomms (35)
Allergies (135)
Alliances (56981)
ALS (171)
Alzheimer's disease (1762)
Antibody-drug conjugate (ADC) (310)
Approvals (18479)
Artificial intelligence (582)
Autoimmune disease (136)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (191)
Biotechnology (488)
Bladder cancer (154)
Brain cancer (62)
Breast cancer (627)
Cancer (4729)
Cardiovascular disease (411)
Career advice (3566)
Career pathing (40)
CAR-T (291)
CDC (59)
Celiac Disease (1)
Cell therapy (789)
Cervical cancer (37)
Clinical research (76604)
Collaboration (1619)
Company closure (5)
Compensation (1075)
Complete response letters (65)
COVID-19 (2980)
CRISPR (93)
C-suite (751)
Cystic fibrosis (148)
Data (5887)
Decentralized trials (2)
Denatured (68)
Depression (133)
Diabetes (498)
Diagnostics (7176)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (277)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (227)
Earnings (99899)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134553)
Executive appointments (1010)
FDA (21244)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1448)
Gene editing (203)
Generative AI (60)
Gene therapy (628)
GLP-1 (1087)
Government (5421)
Grass and pollen (8)
Guidances (380)
Healthcare (20941)
HIV (55)
Huntington's disease (45)
IgA nephropathy (80)
Immunology and inflammation (277)
Immuno-oncology (42)
Indications (77)
Infectious disease (3253)
Inflammatory bowel disease (198)
Inflation Reduction Act (16)
Influenza (114)
Intellectual property (218)
Interviews (816)
IPO (17943)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (653)
Leadership (39)
Legal (10154)
Liver cancer (95)
Longevity (14)
Lung cancer (651)
Lymphoma (361)
Machine learning (40)
Management (66)
Manufacturing (755)
MASH (167)
Medical device (14973)
Medtech (15013)
Mergers & acquisitions (22882)
Metabolic disorders (1303)
Multiple sclerosis (152)
NASH (23)
Neurodegenerative disease (323)
Neuropsychiatric disorders (86)
Neuroscience (2967)
NextGen: Class of 2025 (7703)
Non-profit (5103)
Now hiring (62)
Obesity (625)
Opinion (327)
Ovarian cancer (153)
Pain (192)
Pancreatic cancer (204)
Parkinson's disease (274)
Partnered (35)
Patents (471)
Patient recruitment (415)
Peanut (59)
People (66653)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23657)
Phase II (33243)
Phase III (25066)
Pipeline (3968)
Policy (319)
Postmarket research (3554)
Preclinical (10669)
Press Release (72)
Prostate cancer (230)
Psychedelics (53)
Radiopharmaceuticals (290)
Rare diseases (812)
Real estate (7436)
Recruiting (80)
Regulatory (28602)
Reports (65)
Research institute (2716)
Resumes & cover letters (651)
Rett syndrome (24)
RNA editing (16)
RSV (82)
Schizophrenia (148)
Series A (241)
Series B (178)
Service/supplier (30)
Sickle cell disease (100)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4327)
State (2)
Stomach cancer (19)
Supply chain (107)
Tariffs (97)
The Weekly (117)
Vaccines (1110)
Venture capital (81)
Weight loss (436)
Women's health (79)
Worklife (21)
Date
Today (118)
Last 7 days (627)
Last 30 days (2635)
Last 365 days (33356)
2025 (32787)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (327)
Arkansas (14)
Asia (51343)
Australia (9019)
California (10869)
Canada (3180)
China (1067)
Colorado (457)
Connecticut (481)
Delaware (328)
Europe (118006)
Florida (1591)
Georgia (351)
Hawaii (3)
Idaho (68)
Illinois (896)
India (62)
Indiana (525)
Iowa (22)
Japan (385)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1398)
Massachusetts (8047)
Michigan (343)
Minnesota (632)
Mississippi (6)
Missouri (135)
Montana (34)
Nebraska (27)
Nevada (118)
New Hampshire (81)
New Jersey (2958)
New Mexico (32)
New York (2901)
North Carolina (1539)
North Dakota (10)
Northern California (5128)
Ohio (331)
Oklahoma (22)
Oregon (52)
Pennsylvania (2201)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4177)
Tennessee (168)
Texas (1709)
United States (39515)
Utah (325)
Vermont (1)
Virginia (274)
Washington D.C. (85)
Washington State (920)
West Virginia (4)
Wisconsin (115)
Wyoming (2)
There are 867,251 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
influenza
Moderna Scores $54 Million From CEPI To Fund Bird Flu Vaccine
The money replaces a small portion of a contract Moderna lost when the Department of Health and Human Services canceled $760 million in backing to develop the vaccine, called mRNA-1018.
December 18, 2025
·
1 min read
·
Dan Samorodnitsky
Obesity
Lilly’s Obesity Pill Maintains Weight Loss as Estimated Approval Timelines Inch Closer
Participants in a Phase III trial who switched to Eli Lilly’s orforglipron after 72 weeks of treatment with Wegovy or Zepbound largely maintained their weight loss for up to a year.
December 18, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Maxwell Biosciences Subsidiary Havih Announces Partnership with the Government of Andhra Pradesh
This partnership will establish a new research and production facility in Andhra Pradesh, driving India’s transition toward pharmaceutical leadership and creating high-tech jobs
December 18, 2025
·
4 min read
Press Releases
Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.
Includes Asthma in its strategic plans and Strengthens its Team in 2024-2025
December 18, 2025
·
5 min read
Press Releases
InMed Announces Results of 2025 Annual General and Special Meeting
December 18, 2025
·
4 min read
Press Releases
Restart Life Closes Over-Subscribed Second Tranche Financing
December 18, 2025
·
2 min read
Press Releases
Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
Enrollment momentum accelerates as Company advances toward full enrollment
December 18, 2025
·
7 min read
Press Releases
BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform
December 18, 2025
·
3 min read
Press Releases
Gene-Edited Chickens and the Price of Poultry: Can CRISPR Make Chicken Cheaper?
December 18, 2025
·
1 min read
Press Releases
Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025
·
1 min read
1 of 86,726
Next
